Technical Analysis for GBIO - Generation Bio Co.

Grade Last Price % Change Price Change
grade D 19.71 3.79% 0.72
GBIO closed up 3.79 percent on Friday, July 10, 2020, on 70 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A N/A Down
Historical GBIO trend table...

Date Alert Name Type % Chg
Multiple of Ten Bearish Other 0.00%
New 52 Week Closing Low Bearish 3.79%
Hot IPO Pullback Bullish Swing Setup 3.79%
Narrow Range Bar Range Contraction 3.79%
New 52 Week Closing Low Bearish 2.71%
Multiple of Ten Bearish Other 2.71%
Narrow Range Bar Range Contraction -0.20%
NR7 Range Contraction -0.20%
NR7-2 Range Contraction -0.20%
Multiple of Ten Bearish Other -0.20%

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Generation Bio is an innovative genetic medicines company focused on creating a new class of gene therapy to provide durable, redosable treatments for patients suffering from both rare and prevalent diseases. The company’s non-viral platform incorporates a proprietary high-capacity DNA construct called closed-ended DNA, or ceDNA; a novel cell-targeted lipid nanoparticle delivery system, or ctLNP; and an established, scalable capsid-free manufacturing process. The company is designing therapies to provide targeted delivery of genetic payloads that include large and multiple genes across a broad array of tissues, and to be redosable for individualized and extended treatment throughout a patient’s life. The platform is designed to expand access to treatments for rare diseases and to address prevalent diseases through efficient, scalable manufacturing.
Biotechnology Manufacturing Life Sciences Biology Rare Diseases Emerging Technologies Molecular Biology Gene Therapy Applied Genetics Gene Delivery

Is GBIO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 24.9
52 Week Low 18.51
Average Volume 322,990
200-Day Moving Average 0.00
50-Day Moving Average 0.00
20-Day Moving Average 21.30
10-Day Moving Average 20.09
Average True Range 1.94
ADX 0.0
+DI 11.05
-DI 20.76
Chandelier Exit (Long, 3 ATRs ) 19.09
Chandelier Exit (Short, 3 ATRs ) 24.32
Upper Bollinger Band 24.63
Lower Bollinger Band 17.96
Percent B (%b) 0.26
BandWidth 31.31
MACD Line -1.01
MACD Signal Line -0.66
MACD Histogram -0.3502
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 23.26
Resistance 3 (R3) 23.36 22.26 22.67
Resistance 2 (R2) 22.26 21.36 22.22 22.47
Resistance 1 (R1) 20.99 20.80 21.62 20.89 22.28
Pivot Point 19.89 19.89 20.21 19.85 19.89
Support 1 (S1) 18.62 18.99 19.26 18.53 17.14
Support 2 (S2) 17.52 18.43 17.48 16.95
Support 3 (S3) 16.25 17.52 16.75
Support 4 (S4) 16.16